PAZZAGLI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 10.550
EU - Europa 6.962
AS - Asia 1.869
SA - Sud America 282
OC - Oceania 89
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.828
Nazione #
US - Stati Uniti d'America 10.515
PL - Polonia 2.400
RU - Federazione Russa 1.687
HK - Hong Kong 702
IT - Italia 655
IE - Irlanda 581
SG - Singapore 572
SE - Svezia 542
UA - Ucraina 288
BR - Brasile 261
DE - Germania 249
CN - Cina 221
FI - Finlandia 197
IN - India 117
CH - Svizzera 106
GB - Regno Unito 95
JO - Giordania 90
AU - Australia 89
FR - Francia 70
VN - Vietnam 46
CI - Costa d'Avorio 44
TR - Turchia 44
ID - Indonesia 29
NL - Olanda 27
CA - Canada 19
ES - Italia 18
AT - Austria 14
BE - Belgio 13
SC - Seychelles 12
KR - Corea 10
AR - Argentina 7
MX - Messico 6
ZA - Sudafrica 6
AZ - Azerbaigian 5
BG - Bulgaria 5
IQ - Iraq 5
BD - Bangladesh 4
CZ - Repubblica Ceca 4
EU - Europa 4
MA - Marocco 4
PY - Paraguay 4
VE - Venezuela 4
EC - Ecuador 3
LK - Sri Lanka 3
OM - Oman 3
PA - Panama 3
PK - Pakistan 3
AL - Albania 2
JM - Giamaica 2
JP - Giappone 2
LV - Lettonia 2
MU - Mauritius 2
PE - Perù 2
RO - Romania 2
SA - Arabia Saudita 2
TW - Taiwan 2
UZ - Uzbekistan 2
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 19.828
Città #
Warsaw 2.399
Santa Clara 2.009
Fairfield 1.330
Chandler 655
Woodbridge 643
Ashburn 629
Dublin 580
Seattle 579
Hong Kong 567
Cambridge 522
Wilmington 463
Houston 462
Jacksonville 456
Singapore 300
Ann Arbor 214
Altamura 204
Lawrence 196
Princeton 184
Florence 176
Boardman 128
Boston 116
Bern 98
Buffalo 95
Melbourne 89
San Diego 85
Beijing 79
Mumbai 76
Medford 74
Falls Church 57
Shanghai 52
New York 50
Abidjan 44
Dong Ket 40
Norwalk 40
Izmir 37
Los Angeles 34
Munich 32
Kent 31
Milan 30
Jakarta 29
Bremen 28
Paris 28
Moscow 25
Pune 25
Andover 23
Turku 23
Auburn Hills 22
Helsinki 19
Phoenix 19
Yubileyny 19
Hillsboro 18
Vienna 14
Brussels 12
Frankfurt Am Main 12
São Paulo 12
Verona 12
West Jordan 12
Redwood City 11
Barcelona 10
Toronto 10
Seoul 9
Belo Horizonte 7
Bondeno 7
London 7
Brescia 6
Dearborn 6
Geneva 6
Old Bridge 6
Redmond 6
Rio de Janeiro 6
Rome 6
Tappahannock 6
The Dalles 6
Atlanta 5
Baku 5
Campinas 5
Contagem 5
Fuzhou 5
Guarulhos 5
Palermo 5
Salerno 5
Salvador 5
Sofia 5
Turin 5
Brasília 4
Brooklyn 4
Chicago 4
Istanbul 4
Laurel 4
Nanjing 4
Porto Alegre 4
Prato 4
Stockholm 4
São Bernardo do Campo 4
Amman 3
Amsterdam 3
Aradeo 3
Asunción 3
Augusta 3
Bari 3
Totale 14.435
Nome #
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers 319
Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions 314
A high-resolution melting protocol for rapid and accurate differential diagnosis of thyroid nodules. 310
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers 295
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 284
Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma. 284
Multiparametric analysis of cell-free DNA in melanoma patients. 271
Influence of 17q gain and promoter polymorphisms on mRNA expression of somatostatin receptor type 2 in neuroblastoma. 266
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. 260
Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. 249
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. 247
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 245
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 242
SPIDIA-DNA: an External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses. 236
SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 233
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer 232
Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics 228
Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing 227
null 196
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 177
Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma 177
Application of a filtration and isolation by size technique for the detection of circulating tumor cells in cutaneous melanoma. 168
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 155
Red or white wine assumption and serum antioxidant capacity. 148
Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method 147
Quantitative RT-PCR assay for VEGF mRNA in human tumors of the kidney. 146
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY. 146
The glycopeptide csf114(glc) detects serum antibodies in multiple sclerosis. 146
Centenarians in Tuscany: The role of the environmental factors. 145
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers 144
Implementation of a proficiency testing for the assessment of the preanalytical phase of blood samples used for RNA based analysis. 140
Glycated hemoglobin (HbA1c) measurement in frozen whole blood depends on baseline values of fresh samples. 140
Circulating cell-free DNA in cancer 140
Age-related changes in serum total antioxidant capacity (TAC), dehydroepiandrosterone sulphate (DHEAS) and insulin-like growth factor-1 (IGF-1): evidence in healthy centenarian subjects. 140
Combining qualitative and quantitative imaging evaluation for the assessment of genomic DNA integrity: The SPIDIA experience 140
Adenosine triphosphate release by osmotic shock and hemoglobin A1C in diabetic subjects' erythrocytes. 139
Circulating tumour cells in colorectal cancer 139
The pre-analytical phase of the liquid biopsy 139
An Italian Program of External Quality Control for Quantitative Assays Based on Real-Time PCR with Taq-Man Probes. 138
Real-time PCR detection of Biscogniauxia mediterranea in symptomless oak tissue 138
Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer. 138
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 138
A real-time quantitative PCR assay for the detection of Sphaeropsis sapinea from inoculated Pinus nigra shoots 137
luciferase gene as reporter: comparison with CAT gene and use in transfection and microinjection of mammalian cells 136
Measurement of steroids in human plasma and tissues by isotope dilution mass spectrometry. 136
Urinary carbonic anhydrase IX splicing messenger RNA variants in urogenital cancers 136
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome. 135
Allele specific Taqman–based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients. 135
SPIDIA-RNA: First external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 133
Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. 132
Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. 132
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide. 131
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue 129
Detection of Diplodia pinea in asymptomatic pine shoots and its relation to the Normalized Insolation index 129
BRAFV600E detection in melanoma is highlyimproved by COLD-PCR. 129
Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. 127
Healthy centenarian subjects as living model of "successful aging": A study on fasting glycemia, C-peptide, dehydroepiandrosterone sulphate (DHEAS) and insulin-like growth factor (IGF-1). 123
Improvement of technical and analytical performance in DNA sequencing by external quality assessment-based molecular training. 122
Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma 122
Longevity index (LI%) and centenarity index (CI%): New indicators to evaluate the characteristics of aging process in the Italian population. 122
NUCLEOSIDE ANALOGUES AS RADIOSENSITIZERS IN THE TREATMENT OF LUNG CANCER 121
Analysis of 12q13-15 genes in parosteal osteosarcoma 121
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe 120
Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis. 119
Evaluation of the liquid biopsy for the detection of brafv600e mutation in metastatic melanoma patients 119
Laser microdissection on Norway spruce bark tissue: A suitable protocol for subsequent real-time reverse transcription–polymerase chain reaction (RT-PCR) analysis 118
Comparison of pre- and postsurgical concentrations of blood HER-2 mRNA and HER-2 extracellular domain reflects HER-2 status in early breast cancer. 117
A solid phase chemiluminescent immunoassay (LIA) for testosterone glicuronide in diluted urines. 117
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients 117
Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. 116
Methodologic European external quality assurance for DNA sequencing: the EQUALseq program. 116
Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique 116
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers. 116
Effects of gemcitabine in normal and transformed human lung cell cultures: citotoxicity and increase of radiation sensitivity 116
Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction. 116
Age-related secretion of androstenedione, testosterone and dihydrotestosterone by the human testis. 115
Effect of diet and red wine consumption on serum total antioxidant capacity (TAC), dehydroepiandrosterone-sulphate (DHEAS) and insulin-like growth factor-1 (IGF-1) in Italian centenarians. 114
The meat in the diet of aged subjects and the antioxidant effects of carnosine. 113
Telomerase in urological malignancy 112
Rapid, quantitative nonisoptopic assay for telomerase activity in human tumors 112
An assay procedure for plasma progesterone based on antibody-enhanced chemiluminescence. 111
EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplification. 111
Biological parameters for the choice of antiangiogenic therapy and efficacy monitoring 111
Healthy centenarian subjects: the effect of red wine consumption on liver function tests. 110
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 108
GENE AMPLIFICATION FOR c-erbB-2, c-myc, epidermal growth factor receptor, int-2 and N-myc MEASURED BY QUANTITATIVE PCR WITH A MULTIPLE COMPETITOR TEMPLATE. 108
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas 104
Developments in quantitative PCR. 104
Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate. 104
Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. 103
Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction 102
Circulating nucleic acids in cancer and pregnancy 102
Melting temperature analysis as quantitative method for detection of point mutations. 101
An immunoassay for plasma cortisol based on chemiluminescence. 100
Evaluation of different progesterone-isoluminol conjugates for chemiluminescence immunoassay. 99
Laser-assisted microdissection for real-time PCR sample preparation. 99
High-Resolution Melting Analysis: A new molecular approach for the early detection of Diplodia pinea in Austrian pine 99
The c-erbB-2 oncogene amplification by competitive PCR in aneuploid cell clones flow sorted from breast cancer samples. 98
QUANTITATIVE POLYMERASE CHAIN REACTION-BASED HOMOGENEOUS ASSAY WITH FLUOROGENIC PROBES TO MEASURE C-ERBb-2 ONCOGENE AMPLIFICATION. 98
Tyrosinase mRNA levels in the blood ofuveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression. 97
Totale 15.052
Categoria #
all - tutte 53.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202066 0 0 0 0 0 0 0 0 0 0 0 66
2020/20212.185 206 177 122 322 124 270 79 173 188 248 121 155
2021/20221.160 30 80 79 40 77 81 50 60 76 62 198 327
2022/20232.943 295 557 87 253 243 501 349 155 280 18 73 132
2023/2024967 50 119 168 50 61 140 43 196 15 28 66 31
2024/20256.114 199 660 376 1.013 1.868 666 99 424 302 160 214 133
Totale 19.976